Stockscreener 앱 받기
24.52
0.86%
0.21
전일 마감가:
$24.31
열려 있는:
$24.29
하루 거래량:
1.34M
Relative Volume:
0.83
시가총액:
$2.11B
수익:
$1.13B
순이익/손실:
$62.75M
주가수익비율:
38.92
EPS:
0.63
순현금흐름:
$170.92M
1주 성능:
-9.15%
1개월 성능:
-5.73%
6개월 성능:
+6.52%
1년 성능:
+18.91%
1일 변동 폭
$24.10
$24.92
1주일 범위
$24.10
$28.75
52주 변동 폭
$17.98
$28.75
Progyny Inc Stock (PGNY) Company Profile
명칭
Progyny Inc
전화
212-888-3124
주소
1359 BROADWAY, NEW YORK, NY
PGNY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
24.52 | 2.10B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
331.02 | 307.04B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
78.60 | 103.28B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
ELV
Elevance Health Inc
|
374.87 | 84.88B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
272.21 | 74.24B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
273.28 | 34.15B | 126.36B | 1.30B | 1.55B | 10.67 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-08 | 업그레이드 | Truist | Hold → Buy |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-12 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-08 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-11-13 | 다운그레이드 | Truist | Buy → Hold |
| 2024-09-19 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-08-07 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | 개시 | JMP Securities | Mkt Outperform |
| 2024-05-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-09-27 | 개시 | Canaccord Genuity | Buy |
| 2023-05-22 | 개시 | BTIG Research | Buy |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-01-05 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | 개시 | Truist | Buy |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-11-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-09-30 | 개시 | Berenberg | Buy |
| 2021-08-12 | 개시 | Barclays | Overweight |
| 2021-06-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-04-29 | 재개 | JP Morgan | Overweight |
| 2021-03-10 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-07-01 | 개시 | SVB Leerink | Outperform |
| 2020-06-02 | 개시 | Guggenheim | Buy |
| 2019-11-19 | 개시 | Citigroup | Buy |
| 2019-11-19 | 개시 | Goldman | Buy |
| 2019-11-19 | 개시 | JP Morgan | Overweight |
| 2019-11-19 | 개시 | Piper Jaffray | Overweight |
| 2019-11-19 | 개시 | SVB Leerink | Outperform |
모두보기
Progyny Inc 주식(PGNY)의 최신 뉴스
(PGNY) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Can Progyny’s (PGNY) Modest Guidance Raise Redefine Its Demand Resilience Narrative? - Yahoo Finance
Pullback Watch: Why is Progyny Inc stock going downJuly 2025 Levels & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Progyny Inc (PGNY) Shares Gap Down to $24.7608 on Jan 15 - GuruFocus
Aug Setups: Is Progyny Inc impacted by rising rates2025 Bull vs Bear & Expert Curated Trade Setups - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Regeneron (REGN) and Progyny (PGNY) - The Globe and Mail
Progyny (NASDAQ:PGNY) Reaches New 1-Year HighTime to Buy? - MarketBeat
Progyny Stock (-11%) : JPM Conference Growth Narrative Fails to Impress - Trefis
Progyny (NASDAQ:PGNY) Shares Down 5.9%Time to Sell? - MarketBeat
Progyny, Inc.'s (NASDAQ:PGNY) Stock Is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? - 富途牛牛
Progyny stock to exceed guidance as BofA reiterates Buy rating By Investing.com - Investing.com Canada
Progyny stock to exceed guidance as BofA reiterates Buy rating - Investing.com
Zacks Industry Outlook Highlights Medpace, Enhabit and Progyny - Yahoo Finance
Progyny to discuss updated financial expectations at upcoming JP Morgan healthcare conference - marketscreener.com
Progyny To Discuss Updated Financial Expectations At Upcoming JP Morgan Healthcare Conference - TradingView — Track All Markets
Progyny Inc anticipates Q4 and full year results to be slightly above previously provided financial guidance - marketscreener.com
Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference - The Manila Times
Star Tribune - FinancialContent
Progyny, Inc.'s (NASDAQ:PGNY) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - Yahoo Finance
Progyny (PGNY) Tops Q1 Earnings and Revenue Estimates - sharewise.com
How sustainable is Progyny Inc. stock dividend payout2025 Trading Recap & Fast Moving Stock Watchlists - ulpravda.ru
Why Progyny Inc. stock remains a top recommendationRisk Management & Low Risk Growth Stock Ideas - Улправда
Progyny, Inc. (PGNY) Soars to 52-Week High, Time to Cash Out? - sharewise.com
Progyny stock hits 52-week high at 27.84 USD By Investing.com - Investing.com Nigeria
Why Progyny Inc. stock is seen as undervaluedGap Up & Low Drawdown Investment Ideas - Улправда
Progyny (NASDAQ:PGNY) stock performs better than its underlying earnings growth over last year - Sahm
PGNY: Keybanc Maintains Overweight Rating and Raises Price Targe - GuruFocus
Progyny (PGNY) Stock Hits New High: Keybanc Raises Target to $32News and Statistics - IndexBox
Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent
Progyny (PGNY) Stock Is Up, What You Need To Know - Finviz
Truist Securities upgrades Progyny stock rating to Buy on improved outlook By Investing.com - Investing.com South Africa
Truist Securities upgrades Progyny stock rating to Buy on improved outlook - Investing.com Nigeria
Progyny (NASDAQ:PGNY) Hits New 1-Year High After Analyst Upgrade - MarketBeat
Progyny (NASDAQ:PGNY) Stock Rating Upgraded by Truist Financial - MarketBeat
Progyny stock hits 52-week high at 27.84 USD - Investing.com India
How Progyny Inc. stock trades during market volatilityLayoff News & Safe Entry Point Identification - Улправда
Why Progyny’s Stock Is Quietly Breaking Higher - TipRanks
KeyBanc Maintains Progyny(PGNY.US) With Buy Rating, Raises Target Price to $32 - 富途牛牛
Progyny president’s employment to end December 2025 - MSN
Progyny jumps after CEO Anevski buys $1.93M of common stock - MSN
Liquidity Mapping Around (PGNY) Price Events - Stock Traders Daily
Progyny, Inc. (PGNY) Stock Analysis: Investor Outlook With A Promising 10% Upside - DirectorsTalk Interviews
The Truth About Progyny Inc: Is This Fertility Stock the Next Silent Millionaire Maker? - AD HOC NEWS
Progyny (NASDAQ:PGNY) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Progyny (NASDAQ:PGNY) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Progyny Earnings Notes - Trefis
2 Reasons PGNY is Risky and 1 Stock to Buy Instead - Yahoo Finance
Fort Washington Investment Advisors Inc. OH Has $35.65 Million Stake in Progyny, Inc. $PGNY - MarketBeat
Progyny rises on guidance update - MSN
Pacer Advisors Inc. Has $8.29 Million Stock Holdings in Progyny, Inc. $PGNY - MarketBeat
Progyny Inc (PGNY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
4.99%
자본화:
|
볼륨(24시간):